Are you presenting a Poster at ESMO24?

The ESMO Congress 2024 took place in Barcelona, from September 13 to 17, 2024, at the Fira Barcelona Gran Via.

This significant event, organized by the European Society for Medical Oncology (ESMO), attracted over 30,000 participants, including healthcare professionals, researchers, patient advocates, and industry representatives from around the globe.

If you want your poster to be featured on our website, please tag OncoDaily on LinkedIn and X.

This is part 3 of Poster Presentations from ESMO24:

Jason Brown:

“Proud of my mentee ⁦Albert Jang⁩ who presented our data from UNITE. No decreased efficacy of EV in patients with pre-existing diabetes or neuropathy.”

Toni Choueiri:

“Work from the IMDC database looking at surrogate markers of survival in kidney cancer ESMO2024. Work led by super star MD-scientist Renee Maria Saliby who is now a Yale Internal Medicine program!”

Paolo Tarantino:

“Embracing the full spectrum of HER2 expression for ADC treatment will require the validation of novel quantitative HER2 assays. Glad to move one step in that direction, with the first presentation of HS-HER2 as a predictive assay for T-DXd in metastatic breast cancer.”

Andrea Boutrous:

“Terrific updates by Roberto Borea from Università di Genova CTCs have a role in early detection of recurrence of high-risk.”

Caterina Sposetti:

“Our poster by Francesca Ligorio: fasting-mimicking diet+neoadj tx in Early TNBC reduces blood glucose, insulin, LDH levels and fat mass (no sarcopenia!). LDH ↓ predicts pCR (p=0.04).

Inhibited intratumor glycosis=novel metabolic biomarker of response?”

Rasha Aboelhassan:

“Today I was surprised by the three generations of experts oncologists affiliated with different institutions in Egypt, who came to encourage our young oncologist in the esmo 2024 poster area.

All experts where proudly gathering around the research work presented by our young oncologists who decided to conduct different research: they decided to address the unmet needs of cancer patients to improve the quality of life, and they decided to overcome the challenges faced by young breast cancer patients.

Omnia Korani
Suzy Sami
Zeinab Abdelwhab

Three young oncologists, thanks for your efforts, well done.”

Ibrahim Halil Sahin:

“It is not surprising anymore to see Dr Myriam Chalabi presenting some mind blowing data and no questions these are impactful to practice.

I think it is still important to entertain some thought process and some discussion around these impressive results.”

More posts featuring ESMO24 on oncodaily.com

ESMO24 Poster Presentation Part 1 
ESMO24 Poster Presentation Part 2